University of Houston: Dual-Target Drug Tackles Immunotherapy Resistance in Pancreatic Cancer
May 28, 2026
May 28, 2026
HOUSTON, Texas, May 28 (TNSjou) -- The University of Houston issued the following news:
* * *
New Dual-Target Drug Tackles Immunotherapy Resistance in Pancreatic Cancer
University of Houston Researcher Part of Groundbreaking National Study
By Laurie Fickman -- (713) 743-8454, lafickman@uh.edu
A national team of researchers is reporting a new strategy to treat pancreatic cancer -- by boosting the immune system. Pancreatic ductal ade . . .
* * *
New Dual-Target Drug Tackles Immunotherapy Resistance in Pancreatic Cancer
University of Houston Researcher Part of Groundbreaking National Study
By Laurie Fickman -- (713) 743-8454, lafickman@uh.edu
A national team of researchers is reporting a new strategy to treat pancreatic cancer -- by boosting the immune system. Pancreatic ductal ade . . .